Application | Comment | Organism |
---|---|---|
medicine | the inhibitor may have a therapeutic application by delaying the progression of corneal destruction in Pseudomonas keratitis | Pseudomonas aeruginosa |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
HSCH2(DL)CH[CH2CH(CH3)2]CO-Phe-Ala-NH2 | 2 isomeric forms | Pseudomonas aeruginosa | |
additional information | no inhibition by gentamicin | Pseudomonas aeruginosa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Pseudomonas aeruginosa | P14756 | strain PA-28 | - |
Purification (Comment) | Organism |
---|---|
- |
Pseudomonas aeruginosa |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
azocasein + H2O | - |
Pseudomonas aeruginosa | ? | - |
? | |
furylacryloyl-glycyl-L-leucyl-L-alanine + H2O | 25°C, pH 7.5 | Pseudomonas aeruginosa | furylacryloyl-glycine + L-leucyl-L-alanine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Pseudomonas aeruginosa elastase | - |
Pseudomonas aeruginosa |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0003 | - |
slowly eluting isomer of HSCH2(DL)CH[CH2CH(CH3)2]CO-Phe-Ala-NH2 | - |
Pseudomonas aeruginosa | |
0.0004 | - |
rapidly eluting isomer of HSCH2(DL)CH[CH2CH(CH3)2]CO-Phe-Ala-NH2 | - |
Pseudomonas aeruginosa |